SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-169261
Filing Date
2019-06-10
Accepted
2019-06-10 16:32:00
Documents
1
Period of Report
2019-06-07
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d763181d8k.htm 8-K 16744
  Complete submission text file 0001193125-19-169261.txt   17811
Mailing Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037
Business Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037 202-734-3400
Vanda Pharmaceuticals Inc. (Filer) CIK: 0001347178 (see all company filings)

IRS No.: 030491827 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34186 | Film No.: 19888882
SIC: 2834 Pharmaceutical Preparations